Grants and Contracts Details
Description
ABSTRACT
Triacylglycerides (TAGs) compromise the majority of lipid in a common human diet. Not only
does TAG metabolism vary widely on a person-to-person basis, but its’ dysregulation leads to a
plethora of diseases and metabolic phenotypes. Hypertriglyceridemia is a diagnostic feature of
metabolic syndrome and is positively correlated with risk of cardiovascular disease1, and insulin
resistance2 Lower post-prandial plasma TAG has been linked to lower rates of ischemic events
and deaths from atherosclerotic cardiovascular disease. Physiologic regulation of TAG largely
functions through two organs: dietary absorption via the small intestine and endogenous
production by the liver. In intestinal and hepatic tissues, TAGs are packaged into analogous
vesicles for transport from the Golgi to the plasma membrane (PM): enterocyte chylomicron-
secretory vesicles (CSVs)3 and hepatocyte Post-TGN (Trans Golgi Network) VLDL Transport
Vesicles (PG-VTVs)4. Current literature lacks mechanistic understanding of the molecular
machinery that coordinates the movement, vesicle-PM fusion, and secretion of TLRs
(Triglyceride-Rich Lipoproteins) into circulation34. A more detailed understanding of this process
would provide insight into the pathophysiology of both fasting and post-prandial
hypertriglyceridemia and the relationship between TRLs and cardiovascular risk.
Our lab previously reported that Dennd5b-deficient mice are resistant to diet-induced obesity
and hepatic steatosis. Our preliminary data demonstrate that after ingestion of lipid, Dennd5b-/-
murine enterocytes accumulate CSVs3 and DENND5B-/- human hepatocytes fail to secrete TAG
while maintaining normal intracellular TAG concentrations. These data support a role for the
protein Dennd5b in trafficking post-Golgi TLR-containing vesicles in both the gut and liver.
However, the cellular functions of Dennd5b behind its role in these processes is
unknown. Furthermore, there is a knowledge gap in the existing literature and our
understanding of how such large TRL cargo are secreted from these tissues. The current
proposal will examine the intracellular localization of Dennd5b protein in liver and small
intestinal tissues and will identify DENND5B-interacting proteins that likely participate in the
process of TRL secretion.
Status | Active |
---|---|
Effective start/end date | 1/1/24 → 12/31/25 |
Funding
- American Heart Association: $67,388.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.